Micro-Tech completed the acquisition of a 51% stake in Creo Europe from Creo Medical for €72mn.

Micro-Tech, a manufacturer and exporter of medical stents and disposable biopsy forceps, completed the acquisition of a 51% stake in Creo Europe, a manufacturer and distributer specialist gastroenterology, urology and endoscopy products to healthcare providers, from Creo Medical, a medical device company, in a €72ml. “As a leading Chinese manufacturer of endoscopic diagnostic and therapeutic devices, Micro-Tech has been actively expanding its global distribution channels and seeking strategic partnerships with innovative companies. CME is a key distributor in the European medical device market, with a highly complementary product portfolio and sales network. This acquisition allows us to introduce more high-quality Micro-Tech products into CME’s portfolio, support Creo Medical’s R&D and market expansion, and create new growth opportunities for all parties involved. Micro-Tech, Creo Medical, and CME share a common strategic vision and a unified mission—to deliver better healthcare solutions for patients and physicians.” Xiaohui Long, Micro-Tech Chairman.